ACAD
ACADIA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$27.29
−0.58%Forward multiples
Based on analyst estimates
- P/E forward
- 30.86x
- P/E 2026E
- 43.60x
- P/E 2027E
- 29.43x
- P/E 2028E
- 17.15x
- P/S forward
- 3.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.13x
- PEG TTM
- —
- Price / book
- 3.60x
- Price / sales
- 4.13x
- Price / cash flow
- 24.20x
Enterprise value
- Enterprise value
- $3.8B
- EV / sales
- 3.35x
- EV / EBITDA
- 32.89x
- EV / EBIT
- 44.23x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026